KR20140099277A - 다중특이적 결합제의 자유 결합 파트너의 검출 방법 - Google Patents

다중특이적 결합제의 자유 결합 파트너의 검출 방법 Download PDF

Info

Publication number
KR20140099277A
KR20140099277A KR1020147016700A KR20147016700A KR20140099277A KR 20140099277 A KR20140099277 A KR 20140099277A KR 1020147016700 A KR1020147016700 A KR 1020147016700A KR 20147016700 A KR20147016700 A KR 20147016700A KR 20140099277 A KR20140099277 A KR 20140099277A
Authority
KR
South Korea
Prior art keywords
antibody
binding
antigen
multispecific
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147016700A
Other languages
English (en)
Korean (ko)
Inventor
카이-군나르 슈튜벤라우흐
우베 베쎌스
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20140099277A publication Critical patent/KR20140099277A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
KR1020147016700A 2011-12-19 2012-12-18 다중특이적 결합제의 자유 결합 파트너의 검출 방법 Ceased KR20140099277A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11194350 2011-12-19
EP11194350.2 2011-12-19
PCT/EP2012/075991 WO2013092611A2 (en) 2011-12-19 2012-12-18 Method for the detection of free binding partner of a multispecific binder

Publications (1)

Publication Number Publication Date
KR20140099277A true KR20140099277A (ko) 2014-08-11

Family

ID=47429825

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147016700A Ceased KR20140099277A (ko) 2011-12-19 2012-12-18 다중특이적 결합제의 자유 결합 파트너의 검출 방법

Country Status (10)

Country Link
US (1) US9671394B2 (cg-RX-API-DMAC7.html)
EP (1) EP2795335B1 (cg-RX-API-DMAC7.html)
JP (1) JP6203747B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140099277A (cg-RX-API-DMAC7.html)
CN (1) CN104040350B (cg-RX-API-DMAC7.html)
BR (1) BR112014011535A2 (cg-RX-API-DMAC7.html)
CA (1) CA2853917A1 (cg-RX-API-DMAC7.html)
MX (1) MX349003B (cg-RX-API-DMAC7.html)
RU (1) RU2633488C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013092611A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
CN104105966B (zh) 2012-02-01 2016-10-26 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的结合搭档的方法
BR112015000665A2 (pt) 2012-07-13 2017-06-27 Hoffmann La Roche método para a determinação da quantidade de um anticorpo
CA2926306C (en) * 2013-11-05 2022-12-06 F. Hoffmann-La Roche Ag A method for determining the total amount and/or concentration of an analyte in a sample
WO2015143277A1 (en) * 2014-03-20 2015-09-24 Wellstat Diagnostics, Llc Antibodies and methods for the detection of cell death
ES2761427T3 (es) 2014-12-18 2020-05-19 Hoffmann La Roche Procedimientos para reducir interferencias
AU2018304711B2 (en) 2017-07-20 2025-04-10 Cytomx Therapeutics, Inc. Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
EP3805757A4 (en) 2018-06-04 2022-03-23 Chugai Seiyaku Kabushiki Kaisha Method for detecting complex
WO2020229378A1 (en) * 2019-05-13 2020-11-19 F. Hoffmann-La Roche Ag Interference-suppressed pharmacokinetic immunoassay
KR20220007586A (ko) * 2019-05-13 2022-01-18 리제너론 파마슈티칼스 인코포레이티드 개선된 경쟁적 리간드 결합 검정
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源(北京)药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56128722A (en) * 1980-03-14 1981-10-08 Terumo Corp Removal of antiacetylcholinereceptor antibody and device therefor
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
ZA898290B (en) 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
DE69332377T2 (de) 1992-07-13 2003-07-03 Bionebraska, Inc. Verfahren zur modifizierung rekombinanter polypeptide
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
JPH11352129A (ja) * 1998-06-04 1999-12-24 Mizuho Medeii:Kk 検出装置及び検出方法
US6753189B1 (en) * 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
EP1230552B1 (en) * 1999-11-16 2006-01-11 Genentech, Inc. Elisa for vegf
EP1288308A1 (en) * 2001-08-28 2003-03-05 Roche Diagnostics GmbH A method for the determination of multiple analytes
GB0320459D0 (en) 2003-09-01 2003-10-01 Selective Antibodies Ltd Assay methods and materials
DE102004052729A1 (de) * 2004-10-30 2006-05-04 Roche Diagnostics Gmbh Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten
US20080206782A1 (en) * 2005-03-08 2008-08-28 Genentech, Inc. Methods for Determining the Bivalency of Protein and Antibody Therapeutics
MX2009003562A (es) * 2006-10-04 2009-04-15 Genentech Inc Ensayo elisa para la deteccion de vegf.
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
PE20120591A1 (es) 2009-04-02 2012-05-23 Roche Glycart Ag Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla
WO2010115589A1 (en) 2009-04-07 2010-10-14 Roche Glycart Ag Trivalent, bispecific antibodies
MX2011011925A (es) 2009-05-27 2011-12-06 Hoffmann La Roche Anticuerpos triespecificos o tetraespecificos.
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
CN102207054B (zh) 2010-03-31 2013-03-13 比亚迪股份有限公司 一种混合动力车的爆震控制系统及方法
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法

Also Published As

Publication number Publication date
EP2795335A2 (en) 2014-10-29
BR112014011535A2 (pt) 2017-05-09
CA2853917A1 (en) 2013-06-27
RU2633488C2 (ru) 2017-10-12
JP2015502547A (ja) 2015-01-22
WO2013092611A3 (en) 2013-10-17
CN104040350B (zh) 2016-05-18
CN104040350A (zh) 2014-09-10
MX2014007095A (es) 2014-07-22
MX349003B (es) 2017-07-06
RU2014128510A (ru) 2016-02-10
US20150072359A1 (en) 2015-03-12
WO2013092611A2 (en) 2013-06-27
US9671394B2 (en) 2017-06-06
HK1201920A1 (zh) 2015-09-11
JP6203747B2 (ja) 2017-09-27
EP2795335B1 (en) 2017-09-06

Similar Documents

Publication Publication Date Title
US10761097B2 (en) Method for the detection of a binding partner of a multispecific binder
US9671394B2 (en) Method for the detection of free binding partner of a multispecific binder
CN104471397B (zh) 用于检测多特异性结合物的方法
CN107076761B (zh) 用于测定针对效应子功能抑制的人或人源化药物抗体的抗药物抗体的方法
HK1230718A (en) Method for the detection of a binding partner of a multispecific binder
HK1230718A1 (en) Method for the detection of a binding partner of a multispecific binder
HK1201920B (en) Method for the detection of free binding partner of a multispecific binder
HK1202921B (en) Method for the detection of a binding partner of a multispecific binder
HK1230718B (zh) 用於检测多特异性结合物的结合搭档的方法
HK1242423A1 (en) Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibody
HK1208731B (en) Method for the detection of a multispecific binder

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140618

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20171204

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190513

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190723

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190513

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I